Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
DNA X, Inc. market cap for the quarter ending 2026-08-18 was $5.24M, a 53.12% decline year-over-year.
DNA X, Inc. market cap for the quarter ending 2026-06-30 was $7.66M, a 39.48% decline year-over-year.
DNA X, Inc. market cap for the quarter ending 2026-05-14 was $7.84M.
DNA X, Inc. market cap for the quarter ending 2026-04-21 was $5.85M.
DNA X, Inc. market cap for fiscal 2026 was $5.24M.
DNA X, Inc. market cap for fiscal 2025 was $4.02M.